Back to Search
ARIELLE NAGLER, M.D.
M.D.
Dermatology Physician
NPI: 1215220496IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
272760(NY)
CMS Specialties
PrimaryDERMATOLOGY
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 2011
Research & Publications (20)
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma.
PMID 19608615·Ann Oncol·2010
3-trial
Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study.
PMID 19449238·Amyotroph Lateral Scler·2010
2-rct
BCR-ABL transcripts are not detected in cord blood or the peripheral blood of the newborn child whose mother developed chronic myeloid leukemia while pregnant.
PMID 19640586·Leuk Res·2010
8-other
Interferon-gamma-induced neuronal differentiation of human umbilical cord blood-derived progenitors.
PMID 19458627·Leukemia·2009
8-other
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT.
PMID 19349953·Bone Marrow Transplant·2009
4-observational
Reduced-intensity conditioning for allogeneic stem cell transplantation: 10 years later.
PMID 19561405·Curr Opin Oncol·2009
8-other
High power accelerator-based boron neutron capture with a liquid lithium target and new applications to treatment of infectious diseases.
PMID 19406650·Appl Radiat Isot·2009
8-other
Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation.
PMID 19406828·J Leukoc Biol·2009
8-other
Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
PMID 19188864·Pancreas·2009
7-preclinical
The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation.
PMID 19322207·Leukemia·2009
4-observational
Stem-cell dose for allogeneic hematopoietic stem cell transplantation in hematological malignancies: is more better?
PMID 19672777·Leuk Lymphoma·2009
8-other
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients.
PMID 19342963·J Immunother·2009
3-trial
Interaction between CXCR4 and CCL20 pathways regulates tumor growth.
PMID 19340288·PLoS One·2009
8-other
Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
PMID 19328780·Exp Cell Res·2009
8-other
Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells.
PMID 19440333·PLoS One·2009
8-other
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
PMID 19264678·Blood·2009
4-observational
MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization.
PMID 19197139·J Clin Invest·2009
7-preclinical
Freeze-drying of mononuclear cells derived from umbilical cord blood followed by colony formation.
PMID 19381290·PLoS One·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 222 EAST 41ST STREET, 16TH FLOOR
NEW YORK, NY 10017 - Phone
- (212) 263-5889
Quick Facts
- NPI
- 1215220496
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile